Summary by Moomoo AI
Hansen Pharmaceutical Group Limited filed with Hong Kong Trading and Settlement Limited on 2 April 2024 with Hong Kong Trading and Settlement Limited, covering information as of 31 March 2024. The report shows that the company's regulary/registered capital and issued shares remained unchanged during the reporting period, with the regulated/registered share capital remaining at HK$200,000 and the total issued shares at 5,933,350,070 shares. In addition, the Company confirms that no new securities were issued during the reporting period and that all relevant listing rules requirements and legal regulations have been complied with. The report was presented by the Joint Secretary of the Joint Undertaking, Ms. Chung Cheng.